Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition

Weidong Wu, Ningxian Wei, Lihui Wang, Danhui Kong, Gang Shao, Yingchun Qin, Lixin Wang, Yansheng Du

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Acute traumatic spinal cord injury (tSCI) results in a lifetime of paralysis associated with a host of medical complications. The developing secondary complications of tSCI may result in further chronic neurodegenerative diseases. Sevoflurane preconditioning (SF-PreCon) has shown guaranteed protective effects in myocardial or cerebral ischemic/reperfusion injury. However, the role of SF-PreCon in tSCI still remains to be elucidated. Here, we found that SF-PreCon ameliorated the developing secondary complications through reducing the apoptosis rate and the secretion of inflammatory cytokines in injured spinal cord tissues, and therefore enhancing the recovery after tSCI. Notably, we demonstrated that SF-PreCon ameliorates tSCI through inhibiting Cycloxygenase-2 (COX-2). Importantly, we verified that SF-PreCon inhibits the expression of COX-2 and reduces the apoptosis rate after tSCI via the induction of Caveolin-3 (Cav-3). Taken together, our results suggest that SF-PreCon ameliorates tSCI via Cav-3-dependent COX-2 inhibition and provide an economical and practical method against the secondary injury after tSCI.

Original languageEnglish (US)
Pages (from-to)87658-87666
Number of pages9
JournalOncotarget
Volume8
Issue number50
DOIs
StatePublished - Jan 1 2017

Fingerprint

Caveolin 3
Cyclooxygenase 2
Spinal Cord Injuries
Apoptosis
sevoflurane
Reperfusion Injury
Paralysis
Neurodegenerative Diseases
Spinal Cord
Chronic Disease
Cytokines

Keywords

  • Anaesthesia
  • Cav-3
  • COX-2
  • Sevoflurane preconditioning
  • Traumatic spinal cord injury

ASJC Scopus subject areas

  • Oncology

Cite this

Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition. / Wu, Weidong; Wei, Ningxian; Wang, Lihui; Kong, Danhui; Shao, Gang; Qin, Yingchun; Wang, Lixin; Du, Yansheng.

In: Oncotarget, Vol. 8, No. 50, 01.01.2017, p. 87658-87666.

Research output: Contribution to journalArticle

Wu, Weidong ; Wei, Ningxian ; Wang, Lihui ; Kong, Danhui ; Shao, Gang ; Qin, Yingchun ; Wang, Lixin ; Du, Yansheng. / Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition. In: Oncotarget. 2017 ; Vol. 8, No. 50. pp. 87658-87666.
@article{21b80d326804431ca915559c505a8ed9,
title = "Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition",
abstract = "Acute traumatic spinal cord injury (tSCI) results in a lifetime of paralysis associated with a host of medical complications. The developing secondary complications of tSCI may result in further chronic neurodegenerative diseases. Sevoflurane preconditioning (SF-PreCon) has shown guaranteed protective effects in myocardial or cerebral ischemic/reperfusion injury. However, the role of SF-PreCon in tSCI still remains to be elucidated. Here, we found that SF-PreCon ameliorated the developing secondary complications through reducing the apoptosis rate and the secretion of inflammatory cytokines in injured spinal cord tissues, and therefore enhancing the recovery after tSCI. Notably, we demonstrated that SF-PreCon ameliorates tSCI through inhibiting Cycloxygenase-2 (COX-2). Importantly, we verified that SF-PreCon inhibits the expression of COX-2 and reduces the apoptosis rate after tSCI via the induction of Caveolin-3 (Cav-3). Taken together, our results suggest that SF-PreCon ameliorates tSCI via Cav-3-dependent COX-2 inhibition and provide an economical and practical method against the secondary injury after tSCI.",
keywords = "Anaesthesia, Cav-3, COX-2, Sevoflurane preconditioning, Traumatic spinal cord injury",
author = "Weidong Wu and Ningxian Wei and Lihui Wang and Danhui Kong and Gang Shao and Yingchun Qin and Lixin Wang and Yansheng Du",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.21142",
language = "English (US)",
volume = "8",
pages = "87658--87666",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "50",

}

TY - JOUR

T1 - Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition

AU - Wu, Weidong

AU - Wei, Ningxian

AU - Wang, Lihui

AU - Kong, Danhui

AU - Shao, Gang

AU - Qin, Yingchun

AU - Wang, Lixin

AU - Du, Yansheng

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Acute traumatic spinal cord injury (tSCI) results in a lifetime of paralysis associated with a host of medical complications. The developing secondary complications of tSCI may result in further chronic neurodegenerative diseases. Sevoflurane preconditioning (SF-PreCon) has shown guaranteed protective effects in myocardial or cerebral ischemic/reperfusion injury. However, the role of SF-PreCon in tSCI still remains to be elucidated. Here, we found that SF-PreCon ameliorated the developing secondary complications through reducing the apoptosis rate and the secretion of inflammatory cytokines in injured spinal cord tissues, and therefore enhancing the recovery after tSCI. Notably, we demonstrated that SF-PreCon ameliorates tSCI through inhibiting Cycloxygenase-2 (COX-2). Importantly, we verified that SF-PreCon inhibits the expression of COX-2 and reduces the apoptosis rate after tSCI via the induction of Caveolin-3 (Cav-3). Taken together, our results suggest that SF-PreCon ameliorates tSCI via Cav-3-dependent COX-2 inhibition and provide an economical and practical method against the secondary injury after tSCI.

AB - Acute traumatic spinal cord injury (tSCI) results in a lifetime of paralysis associated with a host of medical complications. The developing secondary complications of tSCI may result in further chronic neurodegenerative diseases. Sevoflurane preconditioning (SF-PreCon) has shown guaranteed protective effects in myocardial or cerebral ischemic/reperfusion injury. However, the role of SF-PreCon in tSCI still remains to be elucidated. Here, we found that SF-PreCon ameliorated the developing secondary complications through reducing the apoptosis rate and the secretion of inflammatory cytokines in injured spinal cord tissues, and therefore enhancing the recovery after tSCI. Notably, we demonstrated that SF-PreCon ameliorates tSCI through inhibiting Cycloxygenase-2 (COX-2). Importantly, we verified that SF-PreCon inhibits the expression of COX-2 and reduces the apoptosis rate after tSCI via the induction of Caveolin-3 (Cav-3). Taken together, our results suggest that SF-PreCon ameliorates tSCI via Cav-3-dependent COX-2 inhibition and provide an economical and practical method against the secondary injury after tSCI.

KW - Anaesthesia

KW - Cav-3

KW - COX-2

KW - Sevoflurane preconditioning

KW - Traumatic spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=85031753493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031753493&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.21142

DO - 10.18632/oncotarget.21142

M3 - Article

AN - SCOPUS:85031753493

VL - 8

SP - 87658

EP - 87666

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 50

ER -